Latest Balance Sheet News

Hawthorn Resources reports exceptional high-grade gold results from a major drilling campaign at its Anglo Saxon project, setting the stage for potential open pit mining development.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Bulletin Resources has sold three non-core tenements of its Lake Rebecca Gold Project to Ramelius Resources for $500,000, enabling a strategic focus on its larger, recently acquired gold ground. The company remains well funded and is advancing exploration plans on high-potential targets.

MFF Capital Investments appoints Gerald Stack as CEO and Managing Director, signaling a strategic evolution with a proposed dividend increase to 10 cents per share.

Resources & Energy Group Limited (REZ) has requested an immediate voluntary suspension of its securities on the ASX as it prepares to announce a capital raising. The suspension is expected to lift by the start of trading on 16 December 2025 or upon the announcement release.

Acusensus Limited has announced a $30 million equity placement to bolster its balance sheet, alongside winning a landmark $34 million contract in Connecticut, marking a significant step in its US expansion. The company also reported multiple contract expansions in Australia and a new debt facility to support its growth ambitions.

Alexium International Group Limited has announced a pro rata non-renounceable rights issue to raise approximately AUD 6.77 million, primarily to repay shareholder loans and finance the acquisition of Microtek Laboratories' microencapsulation business.

Alexium International has acquired Microtek Laboratories’ microencapsulation and phase-change material business, backed by a $6.8 million entitlement offer to strengthen its manufacturing and innovation capabilities in the US.

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Symal Group has locked in a $300 million revolving debt facility with major Australian banks, enhancing its financial flexibility to support strategic growth and acquisitions.

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.